Location History:
- Villeveyrac, FR (2002 - 2006)
- Villeveyrae, FR (2010)
Company Filing History:
4 out of 389 
2 out of 152 
1 out of 12 Years Active: 2002-2025
Title: **Olivier Monnier: Innovator in Pharmaceutical Chemistry**
Introduction
Olivier Monnier is a prominent inventor based in Villeveyrac, France, known for his contributions to the field of pharmaceutical chemistry. With an impressive portfolio of six patents, Monnier has made significant advancements in therapeutics that aim to improve patient outcomes.
Latest Patents
Monnier's recent inventions demonstrate his innovative spirit and dedication to medical science. One of his latest patents is titled "7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydropyrid-1-yl)ethyl)isoquinoline besylate salt, preparation and therapeutic use thereof." This patent pertains to the besylate salt of a specific isoquinoline compound, detailing its preparation methods as well as its therapeutic applications. Additionally, he has developed another patent focusing on "Crystalline forms of osanetant," which explores the crystalline combinations of a complex chemical compound and includes processes for their preparation.
Career Highlights
Throughout his career, Olivier Monnier has worked with reputable companies, including Sanofi-Aventis and Sanofi-Synthelabo, where his expertise in drug development has been invaluable. His work has not only contributed to advancements in pharmacology but also laid the groundwork for future research in the field.
Collaborations
Monnier has collaborated with esteemed colleagues such as Bruno Franc and Christian Hoff. These partnerships have fostered a creative environment that stimulates innovation and enhances the development of new therapeutic solutions.
Conclusion
Olivier Monnier stands out as a key figure in the landscape of pharmaceutical innovation. His contributions, backed by a solid patent portfolio and collaboration with industry leaders, reflect his commitment to enhancing therapeutic strategies and improving healthcare outcomes globally. With each invention, Monnier continues to push the boundaries of what is possible within the realm of pharmaceutical chemistry.